Anti-CD8 monoclonal antibody

Drug Profile

Anti-CD8 monoclonal antibody

Alternative Names: Anti-CD8; Anti-Leu-2; Anti-Ly-2.1

Latest Information Update: 13 Feb 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Becton, Dickinson and Company
  • Class Antiretrovirals; Monoclonal antibodies
  • Mechanism of Action CD8 antigen inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Graft-versus-host disease; Transplant rejection

Most Recent Events

  • 19 Oct 1998 A preclinical study has been added to the pharmacodynamics section
  • 04 Apr 1996 A preclinical study has been added to the pharmacodynamics section
  • 15 Jan 1995 Investigation in Graft-versus-host disease in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top